Unbiased Analysis of Today's Healthcare Issues
Yes, this appears to be the case. Medscape reports: In one of the largest healthcare deals to date, Kaiser Permanente is acquiring Pennsylvania-based Geisinger Health and investing $5 billion to fold it into a new nonprofit subsidiary called Risant Health, which is set to purchase additional medical groups in coming years.While regulators still must review…
A paper by Caraballo et al. (2023) published today uses CDC data to measure excess mortality among Black Americans between 1999-2020. They find that: From 1999 to 2011, the age-adjusted excess mortality rate declined from 404 to 211 excess deaths per 100 000 individuals among Black males (P for trend <.001). However, the rate plateaued from…
Summarized from a nice review paper by Basu, Unuigbe and Masseria (2023). Stratifying by Quintiles of propensity scores (PS). Under this approach, the empirical distribution of the estimated PS across the entire sample (including treated and untreated participants) is divided into quintiles. Indicator variables for the first 4 quintiles are then used as covariates, along…
“I write only when inspiration strikes. Fortunately it strikes every morning at nine o’clock sharp.” W. Somerset Maugham
Three parent baby? Area Deprivation Index only reflects median home price? Organ on a chip? Using the “uptrend effect” to increase rates of exercise. Cognitive activity at work and the risk of dementia
What are the economic consequences of the updated USPSTF recommendations to move the age for annual breast cancer screening to age 40? I was interviewed at NPR’s Marketplace Morning Report today (May 11, 2023) to help answer the question. You can listen to the episode here (the segment on breast cancer screening starts at 5:32).…
As heard at ISPOR 2023 in Boston: On high US drug prices: “My hope as a European is that US never gets its health system in order.” And his Yoda-like pronouncement: “Affordability is important; but value is critical” Michael Drummond HT: Peter Neumann. See also Dr. Neumann’s ISPOR recap thread
Today I’m turning this post over to some of my FTI colleagues in Europe (Antoine Mialhe, Katja Murray and Valeria Fagone among others) who helped summarize the Reform of the EU pharmaceutical legislation that the European Union (EU) adopted on April 26, 2023. The summary below is provided by the FTI Consulting team in Brussels…
Results below from UNESCO data. Presented without commentary. HT: Marginal Revolution
If you’re attending the ISPOR 2023 conference in Boston, MA please feel free to come by view some of my research. This includes the following: Podium Presentation #108: Economic Evaluations of Rare Diseases: “Quantifying the Insurance and Altruism Value for Rare Diseases: A Case Study for Duchenne Muscular Dystrophy”. Jason Shafrin will be presenting this work as…